文献速递肺外科

局限期小细胞肺癌手术中淋巴结评估对结局的影响

Effect of Lymph Node Assessment on Outcomes in Surgery for Limited Stage Small Cell Lung Cancer.
PubMed 文献 · Ann Thorac Surg · 2020-06-13

该研究基于美国国家癌症数据库2004至2015年接受肺叶切除术的1051例局限期(cT1-2N0M0)小细胞肺癌成人患者,分析淋巴结清扫数目与总生存及病理淋巴结升期的关系。多变量分析中仅清扫8至12枚淋巴结与生存获益相关(HR 0.73;95%CI 0.56-0.98),但按连续变量建模时淋巴结数目与生存无关。总体病理淋巴结升期率为19%,连续变量建模下清扫超过7枚淋巴结与淋巴结升期显著相关(OR 1.03;95%CI 1.01-1.06)。

要点

  • 局限期小细胞肺癌肺叶切除时,淋巴结清扫数目与生存无明确连续关联
  • 清扫8至12枚淋巴结与生存获益相关(HR 0.73;95%CI 0.56-0.98)
  • 清扫超过7枚淋巴结与病理淋巴结升期显著相关(OR 1.03;95%CI 1.01-1.06)

核心结论

  • 增加淋巴结清扫数目与局限期小细胞肺癌肺叶切除术后生存无明确差异,但清扫淋巴结数目与病理淋巴结升期相关。

研究设计与样本

  • 回顾性队列研究,查询美国国家癌症数据库2004至2015年接受肺叶切除术的局限期(cT1-2N0M0)小细胞肺癌成人患者,排除生存、分期或淋巴结评估未知及接受新辅助治疗者。
  • 共1051例患者符合标准,淋巴结评估数目同时作为连续变量和按分布四分位分层的分类变量分析。
  • 主要结局为总生存,次要结局为病理淋巴结升期。

主要发现

  • 多变量分析中,仅清扫8至12枚淋巴结与显著生存获益相关(HR 0.73;95%CI 0.56-0.98)。
  • 按连续变量建模时,淋巴结评估数目与生存无关联(HR 1.00;95%CI 0.98-1.02)。
  • 总体病理淋巴结升期率为19%。
  • 连续变量建模下,切除时清扫超过7枚淋巴结与淋巴结升期显著相关(OR 1.03;95%CI 1.01-1.06)。

关键数值与推荐

  • 清扫8至12枚淋巴结与生存获益相关(HR 0.73;95%CI 0.56-0.98)。
  • 清扫超过7枚淋巴结与病理淋巴结升期相关(OR 1.03;95%CI 1.01-1.06)。
  • 总体病理淋巴结升期率为19%。

临床怎么用

  • 局限期小细胞肺癌行肺叶切除术时,可考虑清扫超过7枚淋巴结以评估病理淋巴结升期。
  • 淋巴结清扫数目与生存的关系尚不明确,不应仅以增加数目作为改善生存的唯一目标。

局限性

  • 回顾性数据库研究,可能存在选择偏倚和未测量混杂因素。
  • 生存分析中淋巴结数目仅分类变量显示获益,连续变量无关联,结果不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The National Comprehensive Cancer Network guidelines recommend surgery for limited stage small cell lung cancer (SCLC). However, there is no literature on minimum acceptable lymph node retrieval in surgery for SCLC. METHODS: The National Cancer Database was queried for adult patients undergoing lobectomy for limited stage (cT1-2N0M0) SCLC from 2004 to 2015. Patients with unknown survival, staging, or nodal assessment, and patients who received neoadjuvant therapy were excluded. The number of lymph nodes assessed was studied both as a continuous variable and as a categoric variable stratified into distribution quartiles. The primary outcome was overall survival and the secondary outcome was pathologic nodal upstaging. RESULTS: A total of 1051 patients met study criteria. In multivariable analysis, only a retrieval of eight to 12 nodes was associated with a significant survival benefit (hazard ratio 0.73; 95% confidence interval, 0.56 to 0.98). However, when modeled as a continuous variable, there was no association between number of nodes assessed and survival (hazard ratio 1.00; 95% confidence interval, 0.98 to 1.02). The overall rate of pathologic nodal upstaging was 19%. Modeled as a continuous variable, more than seven lymph nodes assessed at time of resection was significantly associated with nodal upstaging in multivariable regression (odds ratio 1.03; 95% confidence interval, 1.01 to 1.06). CONCLUSIONS: In this study, there was no clear difference in survival based on increasing the number of lymph nodes assessed during lobectomy for limited stage SCLC. However, the number of retrieved lymph nodes was associated with pathologic nodal upstaging. Therefore, patients may benefit from retrieval of more than seven lymph nodes during lobectomy for SCLC.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Rucker AJ, Raman V, Jawitz OK, et al. Effect of Lymph Node Assessment on Outcomes in Surgery for Limited Stage Small Cell Lung Cancer. Ann Thorac Surg. 2020. PMID: 32544452. doi:10.1016/j.athoracsur.2020.04.117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。